• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Gottlieb: Shutdown means furloughs for 42% of FDA staff

Gottlieb: Shutdown means furloughs for 42% of FDA staff

January 22, 2018 By Brad Perriello

FDA 3D printingThe federal government shutdown means that 42% of the FDA’s personnel will go on furlough, commissioner Dr. Scott Gottlieb said today.

“FDA’s current shutdown plan provides for 58% of workforce continuing to work and 42% furloughed. The number of FDA employees continuing to work in this shutdown is projected to be an increase from past shutdowns. FDA user fee programs have grown significantly since 2013,” Gottlieb wrote on Twitter.

The other 58% will stay on duty to conduct surveillance of adverse events for medical devices, drugs and other medical products, Gottlieb said in another Twitter message.

“FDA personnel will continue to review food and drug imports despite the lapse in appropriated funding. This work is mission critical to protecting consumers/patients from harmful products that may cross into the U.S.,” he wrote. “FDA currently has access to carryover user fee funds that allow us to continue to review/approve some types of medical product applications. Ensuring patients have access to novel, beneficial medical products is key part of our work to protect & promote public health.”

The federal safety watchdog will also continue to monitor influenza activity and the supply of anti-viral medications, working with the Centers for Disease Control & Prevention, Gottlieb added. Food recalls and monitoring will also continue, he said.

“The hurricane recovery has been a key focus for FDA; and this mission critical work will continue in earnest during the shutdown. We will not stop working to alleviate the urgent IV saline shortage situation,” Gottlieb concluded.

Filed Under: Food & Drug Administration (FDA), Regulatory/Compliance

More recent news

  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure
  • Ambu wins FDA clearance for first single-use cysto-nephroscope

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy